Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
Joint Authors
Popeskou, S.
Christou, Niki
Meyer, Jeremy
David, Valentin
Buchs, Nicolas
Liot, Emilie
Robert, Joan
Ris, Frederic
Mathonnet, Muriel
Toso, Christian
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-12-16
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Despite many advances in the diagnosis and treatment of colorectal cancer (CRC), its incidence and mortality rates continue to make an impact worldwide and in some countries rates are mounting.
Over the past decade, liquid biopsies have been the object of fundamental and clinical research with regard to the different steps of CRC patient care such as screening, diagnosis, prognosis, follow-up, and therapeutic response.
They are attractive because they are considered to encompass both the cellular and molecular heterogeneity of tumours.
They are easily accessible and can be applied to large-scale settings despite the cost.
However, liquid biopsies face drawbacks in detection regardless of whether we are testing for circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), or miRNA.
This review highlights the different advantages and disadvantages of each type of blood-based biopsy and underlines which specific one may be the most useful and informative for each step of CRC patient care.
American Psychological Association (APA)
Christou, Niki& Meyer, Jeremy& Popeskou, S.& David, Valentin& Toso, Christian& Buchs, Nicolas…[et al.]. 2019. Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019. BioMed Research International،Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1126348
Modern Language Association (MLA)
Christou, Niki…[et al.]. Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019. BioMed Research International No. 2019 (2019), pp.1-11.
https://search.emarefa.net/detail/BIM-1126348
American Medical Association (AMA)
Christou, Niki& Meyer, Jeremy& Popeskou, S.& David, Valentin& Toso, Christian& Buchs, Nicolas…[et al.]. Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1126348
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1126348